MedTrace Logo

Changes in Hematological Parameters With Glycemia Control in Type 2 Diabetes

NCT06228898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2024-01-29

No results posted yet for this study

Summary

There is a systemic low-grade chronic inflammation in diabetes, and research suggests that this inflammation plays a vital role in the development of diabetic complications. Macrovascular complications, which are associated with atherosclerosis, are recognized as a chronic inflammatory disease. In this study, the aim was to evaluate the potential alteration in hematologic inflammatory markers among patients with poorly controlled type 2 diabetes subsequent to the enhancement of diabetes management.

Conditions

  • Poorly Controlled Diabetes Mellitus

Sponsors & Collaborators

  • Goztepe Prof Dr Suleyman Yalcın City Hospital

    lead OTHER

Principal Investigators

  • Ayse N Erbakan, MD · Goztepe Training and Research Hospital

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-15
Primary Completion
2023-01-15
Completion
2023-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06228898 on ClinicalTrials.gov